Healthline: Coronavirus and stroke
Reports detail guidelines, published by UC researchers, about stoke treatments during COVID-19
New research by UC and UC Health experts shows that doctors can perform immediate surgery to treat stroke in COVID-19 patients by using enhanced disinfection methods, according to their paper published in the journal Stroke. But the surgery also can present an ethical issue because not every COVID-19 patient is a good candidate for the invasive, anti-stroke treatment.
Aaron Grossman, MD, PhD, assistant professor in the department of neurology and rehabilitative medicine at the UC College of Medicine and a UC Health physician who is also the corresponding author on the report, is quoted.
The report was covered in Healthline. Grossman and Matthew Smith, MD, lead author of the report, neurocritical care fellow and UC Health physician, provided details.
Cincinnati's NPR affiliate WVXU-FM, 91.7, also hosted Grossman and Smith for a half-hour segment to discuss stroke in the COVID-19 era.
Read about other COVID-19 research being conducted at UC.
Featured photo/Tommy Campbell/UC Health
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.